Delay HCV antivirals after liver transplant, study says

07/14/2010 | Medscape (free registration)

Researchers said hepatitis C patients who have had liver transplants should not start antiviral therapy for one year after surgery unless there is a resurgence of the HCV infection. The study found prophylactic antivirals had no effect on patient or graft survival and were poorly tolerated.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY